다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Vanda Pharmaceuticals Inc (VNDA)
Vanda Pharmaceuticals Inc (VNDA) 뉴스

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/08/15	05:25	KR Market News	공급 경색에도 중국의 경제 둔화 우려로 유가 하락	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/08/12	11:32	KR Market News	소매 투자자들이 페니 주식에 집중: 위워크, 아미리스	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/08/12	05:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/08/11	06:44	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/08/02	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/07/29	05:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/07/28	20:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/07/28	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/07/28	05:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Second Quarter 2023 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/07/21	05:30	PR Newswire (US)	Vanda Pharmaceuticals to Announce Second Quarter 2023 Financial Results on July 27, 2023	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/06/21	05:35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/06/16	05:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/06/13	05:20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/06/13	05:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/06/13	05:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/06/13	05:18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/06/09	05:41	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/06/05	20:00	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation in the Jefferies 2023 Global Healthcare Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/06/02	10:41	PR Newswire (US)	Vanda Pharmaceuticals Announces Presentations at SLEEP 2023	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/06/02	10:31	PR Newswire (US)	Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/05/25	20:00	PR Newswire (US)	Vanda Pharmaceuticals Reports Results from a Phase III study of Tradipitant in Motion Sickness	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/05/11	20:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/05/11	03:26	PR Newswire (US)	Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Appeal	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/05/05	07:00	PR Newswire (US)	Vanda Pharmaceuticals Announces Presentations at DDW 2023	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/05/04	06:11	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/05/04	05:56	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/05/04	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/05/04	05:01	PR Newswire (US)	Vanda Pharmaceuticals Reports First Quarter 2023 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/05/03	02:43	Dow Jones News	Vanda Pharmaceuticals Sues U.S. Government Over Alleged Misuse of Confidential Drug Data	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2023/05/03	01:46	PR Newswire (US)	Vanda Pharmaceuticals Sues Federal Government for Misappropriation of Trade Secrets and Confidential Information	NASDAQ:VNDA	Vanda Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

Health Care Select Sector

US Dollar vs Euro

Bank of America

BNP Paribas (QX)

US Dollar vs Sterling

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

JP Morgan Chase

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관